Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations.

Acta neuropathologica - 1 Dec 2023

Roberts Holly J, Ji Sunjong, Picca Alberto, Sanson Marc, Garcia Mekka, Snuderl Matija, Schüller Ulrich, Picart Thiébaud, Ducray François, Green Adam L, Nakano Yoshiko, Sturm Dominik, Abdullaev Zied, Aldape Kenneth, Dang Derek, Kumar-Sinha Chandan, Wu Yi-Mi, Robinson Dan, Vo Josh N, Chinnaiyan Arul M, Cartaxo Rodrigo, Upadhyaya Santhosh A, Mody Rajen, Chiang Jason, Baker Suzanne, Solomon David, Venneti Sriram, Pratt Drew, Waszak Sebastian M, Koschmann Carl

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Metastases and Treatment
Share to Brain Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cancer, Hypoxia, and Metabolism

Share to Epigenomics

Share to Glioma

Share to Glioma Diagnosis and Treatment

Share to Mutation

Source

Open in PubMed Open full text

Identifiers

PMID: 37851269
DOI: 10.1007/s00401-023-02640-7
PMCID: PMC10627895

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations.PMID 37851269Read ↗

H3K27-altered diffuse midline gliomas with MAPK pathway alterations: Prognostic and therapeutic implications.Semantic proximity Read ↗

A comprehensive genomic study of 390 H3F3A-mutant pediatric and adult diffuse high-grade gliomas, CNS WHO grade 4.Semantic proximity Read ↗

Survival analysis of adult midline-located gliomas and diffuse midline gliomas: beyond the H3K27 mutation paradigm.Semantic proximity Read ↗

New Developments in the Pathogenesis, Therapeutic Targeting, and Treatment of H3K27M-Mutant Diffuse Midline GliomaSemantic proximity Read ↗

Identification of prognostic markers in diffuse midline gliomas H3K27M-mutant.Semantic proximity Read ↗

H3K27-Altered Diffuse Midline Glioma of the Brainstem: From Molecular Mechanisms to Targeted Interventions.Semantic proximity Read ↗

Diffuse midline gliomas with subclonal H3F3A K27M mutation and mosaic H3.3 K27M mutant protein expression.Semantic proximity Read ↗

H3G34-Mutant Gliomas—A Review of Molecular Pathogenesis and Therapeutic OptionsSemantic proximity Read ↗

Clinical, surgical, and molecular characteristics and outcomes of adult patients with diffuse midline glioma, H3 K27-altered, treated with surgical resection.Semantic proximity Read ↗

Clinical, radiologic, and genetic characteristics of histone H3 K27M-mutant diffuse midline gliomas in adultsSemantic proximity Read ↗

H3K27M-mutant diffuse midline gliomas should be further molecularly stratified: an integrated analysis of 669 patients.Semantic proximity Read ↗

Prognostic Indicators for H3K27M-Mutant Diffuse Midline Glioma: A Population-Based Retrospective Surveillance, Epidemiology, and End Results Database Analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.